Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fulcrum Therapeutics

7.12
-0.1300-1.79%
Volume:229.54K
Turnover:1.63M
Market Cap:384.33M
PE:-867.13
High:7.39
Open:7.30
Low:6.99
Close:7.25
Loading ...
Jul 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 31, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

Correspondence

Form CORRESP - Correspondence
Mar 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 22, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Major Issues Report

Form 8-K - Current report